Globus Medical Reports 2Q17 Revenue
Globus Medical reported 2Q17 revenue of US $152.4MM, +10.8% vs. 2Q16, and 1H17 revenue of $308.2MM, +11.4% vs. 1H16. ...
Globus Medical reported 2Q17 revenue of US $152.4MM, +10.8% vs. 2Q16, and 1H17 revenue of $308.2MM, +11.4% vs. 1H16. ...
During 2Q17, Globus Medical acquired KB Medical, Switzerland-based developer of the AQrate™ Robotic Assistance system....
NuVasive reported 2Q17 revenue of US $260.6MM, +10.3% vs. 2Q16, and 1H17 revenue of $510.4MM, +13.1% vs. 1H16. ...
SpineSource was awarded a contract to supply the U.S. Department of Defense with the L-Varlock® expandable lumbar cage....
Blue Cross and Blue Shield has updated its coverage policy for MIS SI joint fusion in various states, and maintained an...
ORTHOWORLD estimates Stryker’s 2Q17 orthopaedic revenue at US $1,618.7MM, +4.0% from 2Q16, and 1H17 revenue of $3,230.9MM, +4.9% vs. 1H16....
ORTHOWORLD estimates Zimmer Biomet 2Q17 orthopaedic revenue of US $1,816.0MM, +2.6% from 2Q16, and 1H17 revenue of $3,652.1MM, +3.7% vs....
In 2Q17 vs. 1Q17, Titan Spine posted a +42% sequential increase in nanoLOCK® surface technology device sales volume....
MiMedx commenced a Phase III study to evaluate AmnioFix Injectable allograft vs. placebo in the treatment of Plantar Fasciitis. ...
AlloSource launched AlloFuse® Select CM cellular allograft for use in spinal, orthopaedic and neurologic procedures. ...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.